Find the best CNRS technologies to boost your innovative project.
30.01.2020
11827-01
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01
We can guide you through the whole technology transfer process.
Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.
85584-01
French patent application FR0213725 filed on October 31, 2002 and entitled “Composition pharmaceutique pour la préparation d’un médicament destiné à traiter et/ou prévenir une pathologie liée à une conduite obsessionnelle”
Valérie COMPAN
Exclusive or non-exclusive licenses and collaborative research.
Centre CNRS-INSERM de Pharmacologie-Endocrinologie (CCIPE, UPR9023), Montpellier, France.
The invention describes the role of 5-HT4 receptors.
The inventors have performed tests in mice and have shown that inactivation of the 5-HT4 receptors helps to a decrease sensitivity to stress-induced anorexia.
5-HT4 receptor antagonists could be used to treat Anorexia and decrease sensitivity to drug abuse. Moreover, 5-HT4 receptor agonists could be used to treat bulimia and hyperphagia.
29.10.2014
Health / Therapeutic 02056-01
15.09.2014
Health / Therapeutic 00472-01
03.10.2013
Health / Therapeutic 86877-07
30.01.2020
11827-01
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01